ArticleCureus2025
Comparing the Effectiveness of 0.12% Chlorhexidine and Silver Nanoparticles Mouthwashes: A Double-Blind Randomized Controlled Trial Among Medical Students in Southern Vietnam.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDental plaque and gingivitis are prevalent conditions that can be controlled using antimicrobial mouthwashes. AIM AND
designThis double-blind, randomized controlled clinical trial aims to compare the effectiveness of 0.12% chlorhexidine (CHX) and silver nanoparticles (AgNPs) mouthwashes in managing dental plaque, gingivitis, microbial counts, and saliva pH. MATERIALS AND
methodsA total of 95 medical students were randomly divided into three groups: Group I (control group), 0.9% sodium chloride; Group II, 0.12% CHX mouthwash; and Group III, AgNPs mouthwash. Clinical parameters evaluated on the baseline and 21stday included the gingival index, Quigley-Hein plaque index (QHI), microbial counts, and saliva pH. The analysis of variance (ANOVA), Tukey post-hoc test, and paired t-tests were implemented.
resultsThe QHI in Group II decreased from 2.66 ± 0.75 to 1.97 ± 0.61 after 21 days (p < 0.001). Specifically for the QHI, there is a statistically significant difference between Group II and Group III, while there is no statistically significant difference when comparing the two groups in other clinical indices, and both groups showed a noticeable improvement after 21 days of use.
conclusionsBoth 0.12% CHX and AgNPs mouthwashes are appropriate alternative options for daily oral hygiene. However, CHX mouthwash should still be prioritized for plaque control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.